Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
2369 On Other Exchanges
2369 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

medibic group (2369) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIBIC GROUP (2369)

Related News

No related news articles were found.

medibic group (2369) Related Businessweek News

No Related Businessweek News Found

medibic group (2369) Details

MediBIC Group, Co., Ltd. provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group, Co., Ltd. was founded in 2000 and is headquartered in Tokyo, Japan.

29 Employees
Last Reported Date: 03/30/15
Founded in 2000

medibic group (2369) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medibic group (2369) Key Developments

MediBIC Group, Co., Ltd., Annual General Meeting, Mar 27, 2015

MediBIC Group, Co., Ltd., Annual General Meeting, Mar 27, 2015.

MediBIC Group, Co., Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2014; Provides Earnings Guidance for the First Half Ending Jun. 2015 and Full Year Ending Dec. 2015

MediBIC Group, Co., Ltd. announced consolidated earnings results for the year ended December 31, 2014. For the period, the company reported net sales of JPY 346 million compared with JPY 230 million for the same period a year ago. Operating loss was JPY 274 million compared with JPY 234 million for the same period a year ago. Ordinary loss was JPY 304 million compared with JPY 280 million for the same period a year ago. Net loss was JPY 356 million or JPY 12.35 per share compared with JPY 288 million or JPY 10.83 per share for the same period a year ago. Negative return on equity was 38.4% compared with 44.2% for the same period a year ago. Cash used in operating activities was JPY 322 million compared with JPY 234 million for the same period a year ago. The company provided earnings guidance for the first half and full year of 2015. For the first half, the company expects to report net sales of JPY 117 million, operating loss of JPY 202 million, ordinary loss of JPY 200 million and net loss of JPY 201 million or JPY 6.92 per share. For the full year, the company expects to report net sales of JPY 704 million, operating income of JPY 6 million, ordinary income of JPY 10 million and net income of JPY 10 million or JPY 0.35 per share.

MediBIC Group, Co., Ltd. to Report Fiscal Year 2014 Results on Feb 12, 2015

MediBIC Group, Co., Ltd. announced that they will report fiscal year 2014 results on Feb 12, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2369:JP ¥246.00 JPY +7.00

2369 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2369.
View Industry Companies

Industry Analysis


Industry Average

Valuation 2369 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 20.7x
Price/Book 7.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 20.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIBIC GROUP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at